Crinetics Pharmaceuticals (CRNX) Other Working Capital Changes (2017 - 2026)

Crinetics Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$685000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 89.75% year-over-year to -$685000.0 in Q1 2026; TTM through Mar 2026 was -$1.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.8 million, down 2579.73% from the prior year.
• Other Working Capital Changes retreated to -$685000.0 in Q1 2026 per CRNX's latest filing, from $743000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $20.3 million in Q3 2025 and bottomed at -$10.3 million in Q3 2023.
• The 5-year median for Other Working Capital Changes is $476000.0 (2022), against an average of $2.0 million.
• Across the five-year window, Other Working Capital Changes surged 200.81% in 2025 and plunged 89.75% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$737000.0 in 2024, then jumped by 200.81% to $743000.0 in 2025, then tumbled by 192.19% to -$685000.0 in 2026.
• Per Business Quant, the three latest CRNX Other Working Capital Changes figures stand at -$685000.0 (Q1 2026), $743000.0 (Q4 2025), and -$361000.0 (Q1 2025).